|
Sorted by: Date | Top Results
|
|
Author |
|
Date |
| |
| |
| 1. |
Re: BMO Capital Conference Friday 
from BMO web pages... Healthcare Ambitious healthcare
companies need a knowledgeable partner to assist with
major transactions as they grow. Our Healthcare team
averages more than 15...
Business & Finance > Investments > Stocks (A to Z) > Stocks N >
Nektar Therapeutics (NKTR)
|
|
jprazsky |
|
8-Feb-10 12:52 pm |
| |
| 2. |
Roche 2009 annual report
The revenue from Mircera and Pegasys are small but
still may help... In a highly competitive, price-sensitive
market, sales of the renal anemia medication Mircera
(methoxy polyethylene glycol-epoetin beta), which
is now...
Business & Finance > Investments > Stocks (A to Z) > Stocks N >
Nektar Therapeutics (NKTR)
|
|
jprazsky |
|
3-Feb-10 04:34 am |
| |
| 3. |
Re: Depomed presentation 2/9
The good news is that solvay seem to move things ahead..
A New Drug Applications for DM-1796 is expected to
be filed with the FDA in the first quarter of 201
0.
Business & Finance > Investments > Stocks (A to Z) > Stocks D >
DepoMed, Inc. (DEPO)
|
|
jprazsky |
|
2-Feb-10 09:06 am |
| |
| 4. |
Re: AstraZeneca Earning 1/28@ 8:30 am
It just seems that it takes them a long time to start
the PIII, just listen to the AZN presentation, had
one more slide on that but no data on the PIII start
while other drugs...
Business & Finance > Investments > Stocks (A to Z) > Stocks N >
Nektar Therapeutics (NKTR)
|
|
jprazsky |
|
28-Jan-10 09:40 am |
| |
| 5. |
Re: AstraZeneca Earning 1/28@ 8:30 am
You’ve talked in the past about collaboration rather
than consolidation and you’ve recently announced several
deals. Is this the way forward for you then? I think
that the power of...
Business & Finance > Investments > Stocks (A to Z) > Stocks N >
Nektar Therapeutics (NKTR)
|
|
jprazsky |
|
28-Jan-10 06:35 am |
| |
| 6. |
Re: AstraZeneca Earning 1/28@ 8:30 am
no news .... On 24 September 2009, AstraZeneca and
Nektar Therapeutics announced an exclusive worldwide
license agreement for two drug development programmes:
NKTR-118, a late stage investigational product...
Business & Finance > Investments > Stocks (A to Z) > Stocks N >
Nektar Therapeutics (NKTR)
|
|
jprazsky |
|
28-Jan-10 06:19 am |
| |
| 7. |
Depomed presentation 2/9
http://www.ceo.bio.org/opencms/ceo/2010/Companies/BIO_CEO_2010_Program_Schedule_01_21_10.pdf
presentation on 2/9 at 10.30 am at the BIOCEO con
ference...
Business & Finance > Investments > Stocks (A to Z) > Stocks D >
DepoMed, Inc. (DEPO)
|
|
jprazsky |
|
22-Jan-10 02:09 am |
| |
| 8. |
AZN NKTR-118/119
Anyone guess when the PIII for NKTR-118 might start
? seem like a long time since the agreement and no
news that I could find...
Business & Finance > Investments > Stocks (A to Z) > Stocks N >
Nektar Therapeutics (NKTR)
|
|
jprazsky |
|
21-Jan-10 07:41 am |
| |
| 9. |
Re: Great presentation from Robin!
found an interesting message at the ONTY message board...
Sounds good to me.. :-) An acquaintance who attended
the Merck presentation yesterday informed me that
there were...
Business & Finance > Investments > Stocks (A to Z) > Stocks N >
Nektar Therapeutics (NKTR)
|
|
jprazsky |
|
13-Jan-10 03:52 am |
| |
| 10. |
Re: NKTR-102 great results
It would be good to hear also some news on the NKTR-118/119
progress with AZN like the start of the PIII... and
the NKTR-105...
Business & Finance > Investments > Stocks (A to Z) > Stocks N >
Nektar Therapeutics (NKTR)
|
|
jprazsky |
|
12-Jan-10 09:56 am |
| |
| 11. |
NKTR-102 great results
Seem to be very good results with the ovarian cancer
study
Business & Finance > Investments > Stocks (A to Z) > Stocks N >
Nektar Therapeutics (NKTR)
|
|
jprazsky |
|
12-Jan-10 09:09 am |
| |
| 12. |
amikacin (NKTR-061)
The resulst sound promising, though the last sentence
about the clinical impact does not sound too enthusiastic..
The source of the info is not clear, I guess its an
abstract from a meeting. suggest from...
Business & Finance > Investments > Stocks (A to Z) > Stocks N >
Nektar Therapeutics (NKTR)
|
|
jprazsky |
|
11-Dec-09 05:10 am |
| |
| 13. |
Re: The Oppenheimer Feedback Loop
Just to add new info for the Oppenheimer funds story
As of 10/31/2009 NEKTAR represents 6.1 % of the fund...
with total assets of 2.5 bilion... so it seema to
be the same, no big sales.... https...
Business & Finance > Investments > Stocks (A to Z) > Stocks N >
Nektar Therapeutics (NKTR)
|
|
jprazsky |
|
18-Nov-09 08:46 am |
| |
| 14. |
Re: New lawsuit ?
At least it suggests that the technology is usefull...
Lets hope it wont have any negative effect ...
Business & Finance > Investments > Stocks (A to Z) > Stocks D >
DepoMed, Inc. (DEPO)
|
|
jprazsky |
|
10-Nov-09 09:36 am |
| |
| 15. |
New lawsuit ?
http://www.businesswire.com/portal/site/google/?ndmViewId=news_view&newsId=20091110005564&newsLang=en
MENLO PARK, Calif.--(BUSINESS WIRE)--Depomed, Inc.
(NASDAQ:DEPO) today announced that it has received
a...
Business & Finance > Investments > Stocks (A to Z) > Stocks D >
DepoMed, Inc. (DEPO)
|
|
jprazsky |
|
10-Nov-09 09:27 am |
| |
| 16. |
Off-label use of drugs also neurontin
Interesting "review" article on Off-label
drug use... including Pfizer Neurontin case http:
//www.bloomberg.com/apps/news?pid=20601109&sid=a4y
V1nYxCGoA&pos=10
Business & Finance > Investments > Stocks (A to Z) > Stocks D >
DepoMed, Inc. (DEPO)
|
|
jprazsky |
|
9-Nov-09 04:42 am |
| |
| 17. |
Santaurus glumetza sales
Santaurus Q3 2009 Grew GLUMETZA (metformin HCl extended
release tablets) total prescriptions to approximately
74,000, up 9.2% sequentially compared with the second
quarter of...
Business & Finance > Investments > Stocks (A to Z) > Stocks D >
DepoMed, Inc. (DEPO)
|
|
jprazsky |
|
5-Nov-09 12:43 pm |
| |
| 18. |
Masco (Behr) 3Q 2009 results
www.masco.com maco owns behr paint that uses NKTR nanoparticles
in paint The negative market conditions were partially
offset by increased sales volume of...
Business & Finance > Investments > Stocks (A to Z) > Stocks N >
Nanophase Technologies (NANX)
|
|
jprazsky |
|
27-Oct-09 08:33 am |
| |
| 19. |
MSN money rumors...
It was also rumored that Astellas, Japan's second
largest pharmaceutical company, was showing interest
in Nektar Therapeutics (NKTR 9.26 -0.03).Like many
of today's rumors however...
Business & Finance > Investments > Stocks (A to Z) > Stocks N >
Nektar Therapeutics (NKTR)
|
|
jprazsky |
|
22-Oct-09 12:03 pm |
| |
| 20. |
CIMZIA sales strong
Strong early roll-out of major new products Cimzia®,
Vimpat® and Neupro® Prescription data for Cimzia (certolizumab
pegol) in the treatment of Crohn's disease (CD)
and rheumatoid arthritis (RA) in the U.S. are...
Business & Finance > Investments > Stocks (A to Z) > Stocks N >
Nektar Therapeutics (NKTR)
|
|
jprazsky |
|
22-Oct-09 01:33 am |
| |